Viewing Study NCT03342950



Ignite Creation Date: 2024-05-06 @ 10:45 AM
Last Modification Date: 2024-10-26 @ 12:35 PM
Study NCT ID: NCT03342950
Status: TERMINATED
Last Update Posted: 2021-10-21
First Post: 2017-11-01

Brief Title: The Effects of Topical Treatment With Clonidine Pentoxifylline in Patients With Neuropathic Pain
Sponsor: Terence J Coderre
Organization: McGill University Health CentreResearch Institute of the McGill University Health Centre

Study Overview

Official Title: The Effects of Topical Treatment With Clonidine Pentoxifylline in Patients With Neuropathic Pain
Status: TERMINATED
Status Verified Date: 2021-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Low recruitment due to the COVID-19 pandemic
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TTNP
Brief Summary: Microvascular dysfunction underlies pain in different animal models of neuropathic pain Pentoxifylline is a phosphodiesterase inhibitor that reduces cyclic adenosine monophosphate cAMP hydrolysis enhances blood flow and reduces platelet aggregation decreases blood viscosity and increases the flexibility of red blood cells all of which relieve microvascular dysfunction Clonidine is an α2-adrenergic receptor agonist that decreases sympathetic outflow from the brainstem vascular reactivity and has direct peripheral vasodilatory action Topical combination of pentoxifylline and clonidine produced significant antiallodynic effects in rat models of neuropathic pain with sciatic nerve injury painful diabetic neuropathy and chemotherapy-induced painful neuropathy In healthy volunteers with an experimentally-induced surrogate for neuropathic pain post-capsaicin tourniquet exposure the topical combination reduced areas of dynamic allodynia and mechanical hyperalgesia in addition to reducing post-capsaicin ischemic pain

This study will investigate if the same topical combination of clonidine pentoxifylline will relieve pain in patients with neuropathic pain following traumatic injuries of peripheral nerves
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None